Marie‐Anne Peyronneau

Increased microglial activation in patients with Parkinson disease using [18F]-DPA714 TSPO PET imaging

Sonia Lavisse, Sébastien Goutal, Catriona Wimberley et al. · Parkinsonism & Related Disorders · 2020 · 123 citations

Neuroimaging Biomarkers, Microglial Activation, Medicine +9

Optimization of yeast‐expressed human liver cytochrome <i>P</i>450 3A4 catalytic activities by coexpressing NADPH‐cytochrome <i>P</i>450 reductase and cytochrome <i>b</i>₅

Marie‐Anne Peyronneau, Jean‐Paul Renaud, Gilles Truan et al. · European Journal of Biochemistry · 1992 · 88 citations · Full text

[¹¹C]SL25.1188, a new reversible radioligand to study the monoamine oxidase type B with PET: Preclinical characterisation in nonhuman primate

Wadad Saba, Héric Valette, Marie‐Anne Peyronneau et al. · Synapse · 2009 · 83 citations · Full text

Neurotransmitter, Pharmacotherapy, Experimental Pharmacology +22

Metabolism and Quantification of [18F]DPA-714, a New TSPO Positron Emission Tomography Radioligand

Marie‐Anne Peyronneau, Wadad Saba, Sébastien Goutal et al. · Drug Metabolism and Disposition · 2012 · 71 citations

Optimized Quantification of Translocator Protein Radioligand ¹⁸F-DPA-714 Uptake in the Brain of Genotyped Healthy Volunteers

Sonia Lavisse, Daniel García-Lorenzo, Marie‐Anne Peyronneau et al. · Journal of Nuclear Medicine · 2015 · 65 citations · Full text